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INTRODUCTION
Labor induction involves artificial stimulation of child-
birth before the natural, spontaneous onset of labor. It is one 
of the most common procedures in modern obstetrics. The 
frequency of labor induction has doubled in recent decades 
due to the development of perinatology and methods of 
monitoring fetal well-being in particular. Currently, one in 
five pregnant women and 30–40% of women delivering 
vaginally undergo this procedure [1]. Reasons for induction 
include reduction of the perinatal mortality and morbidity 
of the fetus and newborn, as well as the reduction of mater-
nal complications. However, as every medical intervention, 
labor induction is associated with a risk of complications. 
QUALIFICATION FOR LABOR INDUCTION
The risks and benefits associated with labor induction 
should always be considered in medical management. 
From the perspective of the child, premature termination 
of pregnancy may lead to neonatal complications. Conserva-
tive treatment, however, increases the risk of intrauterine 
hypoxia caused by placental insufficiency or intrauterine 
infection in cases of cervical dilation or premature rupture 
of membranes. On the one hand, induction of labor reduces 
a threat to life and health of the mother, for example, in preg-
nancies complicated by preeclampsia; on the other hand, 
it increases the risk of prolonged labor, uterine atony, ob-
stetric hemorrhage and cesarean section. When qualifying 
a pregnant woman for induction of labor, one should al-
ways take account of gestational age based on ultrasound 
examination performed in the first trimester, the severity of 
the irregularities observed, parity, the maturity of the cervix 
and the presence of any contraindications (Tab. 1).
The history of the disease should include a document 
qualifying for labor induction based on clinical data. Before 
the planned induction, the pregnant woman must give 
informed consent. 
Recommendation
The decision to induce labor should always be 
justified on medical grounds and preceded by 
obtaining a written informed consent from the 
pregnant woman. 
Table 1. Contraindications to labor induction
Contraindications to labor induction
Placenta or vasa previa
Surgical procedures on the uterine body (e.g. classical 
cesarean section, enucleation of uterine fibroids)
Intrapartum uterine rupture
Invasive cancer of the cervix
Active genital herpes infection
Abnormal fetal position (transverse, breech)
Other contraindications to vaginal delivery
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INDICATIONS FOR LABOR INDUCTION
A post-term pregnancy
A post-term pregnancy is defined as a pregnancy that 
lasts more than 42 weeks (294 days or more from the first 
day of the last menstrual period). The International Statisti-
cal Classification of Diseases and Related Health Problems 
(ICD-10) from 2015 uses the term ‘a prolonged pregnancy’, 
which covers a post-term pregnancy. A post-term fetus is 
defined as a fetus in gestation lasting full 42 weeks or more 
(294 days or more from the first day of the last menstrual 
period). A full-term pregnancy is defined as a pregnancy 
at 37 weeks to 40 weeks + 6 days, whereas a late-term 
pregnancy is a pregnancy at 41 weeks to 41 weeks + 6 days. 
Diagnosing a pregnancy that lasts 42 weeks or longer involves 
estimating the date of delivery based on the date of the last 
menstrual period or ultrasound examination. If the date of 
delivery is estimated on the basis of ultrasound examination 
in the first trimester, the incidence of post-term pregnan-
cies is approximately 2% and labor is induced less often 
than in pregnancies in which the date of delivery is deter-
mined by the date of the last menstrual period [2, 3]. Pre- 
vious post-term pregnancy increases the risk of recurrence 
in subsequent pregnancies. The risk of anther post-term 
pregnancy is two- to fourfold higher, and even higher in 
the case of two consecutive post-term pregnancies in the 
past  [4]. Meta-analyses of randomized trials indicate that 
labor induction in uncomplicated post-term pregnancies is 
associated with a reduced risk of intrauterine fetal death and 
a lower rate of caesarean sections, compared to expectant 
management. It has also been found that labor induction in 
post-term pregnancies is associated with reduced perinatal 
morbidity and in particular a lower risk of meconium aspira-
tion [1, 5]. Labor induction is therefore justified in well-dated, 
single, uncomplicated pregnancies between 41 weeks and 
41 weeks + 6 days regardless of the state of the cervix. If 
a woman decides not to have her labor induced further 
care and monitoring should be carried out in a hospital [6]. 
Increased prenatal control should include ultrasound evalu-
ation of amniotic fluid volume and at least one cardioto-
cographic record per day [7]. Induction of labor should be 
discussed again with a pregnant woman diagnosed with 
oligohydramnios and/or irregularities in the cardiotoco-
graphic records indicative of a threat to fetal well-being. 
Recommendation
Labor induction is recommended in well-dated 
pregnancies (taking account of fetal biometry 
between 8 and 14 weeks of gestation) at 41  
weeks to 41 weeks + 6 days, regardless of the 
state of the cervix, taking account of the fact 
that interventions at this time reduce perinatal 
mortality without increasing perinatal morbidity 
or the percentage of caesarean sections.
Pre-term pre-labor rupture of membranes  
before 37 weeks of gestation
Pre-term pre-labor rupture of membranes (PPROM) be-
fore 37 weeks of gestation occurs in 3% of pregnancies and is 
the cause of 1/3 of pre-term deliveries. The fetus/infant is ex-
posed to a higher risk of morbidity and mortality associated 
with PPROM than the mother. The management of women 
with PPROM must take account of a number of factors, 
including gestational age, the availability of the intensive 
care unit, the presence of infection in the mother/fetus, the 
onset of uterus contraction, placental abruption, the posi-
tion of the fetus, the fetal heart rate and prediction of fetal 
lung maturity, and the maturity of the cervix. Labor induc-
tion in women with PPROM is clinically justified in cases of 
intrauterine infection, when fetal health may deteriorate as 
a result of expectant management and there are no available 
therapeutic methods other than delivery.
The results of randomized trials comparing direct labor 
induction and expectant management do not indicate sig-
nificant differences in the incidence of maternal-fetal com-
plications before 37 weeks of pregnancy in the absence of 
symptoms of infection in the mother and intrauterine fetal 
asphyxia [8–10]. A 48-hour antenatal corticosteroid therapy 
is recommended before 34 weeks of gestation in order to re-
duce the risk of neonatal complications [11]. It is not recom-
mended to repeat corticosteroid therapy if delivery does not 
occur within seven days, during the period of their optimum 
action [12]. The results of randomized trials suggest that the 
use of prophylactic antibiotics in PPROM before the onset 
of contractions before 37 weeks of gestation can reduce the 
risk of intrauterine infection and lengthen the pregnancy. 
The combination of amoxicillin and clavulanic acid should 
be avoided in prophylactic therapy due to an increased risk 
of necrotising enterocolitis in prematurely born infants [13].
Recommendations
1. Labor induction is not recommended in preg-
nant women with PPROM before 34 weeks 
of gestation in the absence of symptoms 
of intrauterine infection due to a high risk 
of complications associated with pre-term 
birth. Expectant management using a steroid 
therapy and antibiotic prophylaxis is recom-
mended.
2. Labor induction is not recommended in preg-
nant women with PPROM between 34 and 
37 weeks of gestation in the absence of 
symptoms of intrauterine infection because 
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it does not reduce the risk of complications of 
neonatal sepsis and may be associated with 
a higher risk of respiratory complications in 
newborns. Expectant management with pro-
phylactic antibiotics is recommended.
3. The labor in women with PPROM is recom-
mended in cases of intrauterine infection, re-
gardless the gestational age. Labor approach 
need to be adequate to clinical conditions. 
PPROM after 37 weeks of gestation
PPROM before the onset of contractions occurs in 8% 
of full-term pregnancies [14]. In expectant management, 
spontaneous uterine contractions occur within 72 hours in 
95% of women with PPROM [14]. Active management aimed 
at the induction of uterine contractions through the admi- 
nistration of oxytocin or prostaglandins reduces the risk of 
inflammatory complications in the mother without increas-
ing the incidence of operative delivery [15]. The results of 
randomized trials also indicate that antibiotic therapy and 
hospitalization in intermediate and intensive care units are 
less likely after labor induction [15]. The use of antibiotics 
is recommended in pregnant in women with positive or 
unknown group B streptococcus (GBS) colonization [16]. 
Recommendation
Labor induction is recommended in pregnant 
women with PPROM after 37 weeks of gestation 
due to a reduced risk of maternal and neonatal 
complications.
Suspected large-for-gestational-age fetuses
Each fetus with a weight above the 90th percentile for 
the gestational age can be considered large for gestational 
age (LGA). Estimated weight amounting to 4,500 grams is 
generally treated as the threshold value in the diagnosis 
of macrosomia. Macrosomia is an important indication for 
an operative delivery and may be the cause of adverse 
perinatal outcome and in particular traumatic injuries to 
mothers and infants [17, 18]. Macrosomia may be related to 
constitutional factors (e.g. family history, male sex, ethnicity), 
environmental factors (diabetes in the mother, weight gain 
in the mother, maternal obesity, post-term pregnancy) or ge-
netic disorders (Pallister-Killian syndrome, Beckwith-Wiede-
mann syndrome, etc.) [19, 20]. Two-dimensional ultrasound 
is commonly used to diagnose macrosomia and LGA. The 
Hadlock formula (including biparietal diameter [BPD], ab-
dominal circumference [AC] and femur length [FL]) has the 
highest predictive value in a population of people with-
out diabetes [21]; AC > 35 cm have predictive values for 
macrosomia, but no test is sufficiently sensitive and spe-
cific [22]. It should be noted that all methods currently used 
to estimate the size of a fetus, especially of a large fetus, 
have little predictive value. The margin of error may reach 
15–20%, especially in suspected macrosomia and advanced 
delivery. Therefore, there is no conclusive evidence that 
labor induction can reduce the morbidity of mothers and 
newborns in pregnancies with suspected fetal macrosomia. 
The results of randomized trials conducted in 19 centers in 
France, Switzerland and Belgium have demonstrated that 
labor induction between 37 and 39 weeks of pregnancies 
with LGA fetuses diagnosed by ultrasound (above the 90th 
percentile for the gestational age) reduces the risk of shoul-
der dystocia and the related neonatal morbidity compared 
with expectant management [23]. However, the number 
needed to prevent one neonatal clavicular fracture during 
labor induction was 60 [24]. There were no significant dif-
ferences in the percentage of caesarean sections, but early 
induction of labor improved the chance for vaginal delivery. 
Unfortunately, there were more cases of vaginal cracking 
and damage to the anal sphincter in the group of women 
who had their labor induced. The neonatal complications 
included a higher incidence of hyperbilirubinemia and the 
need for phototherapy in neonates after labor induction, 
especially before 38 weeks of gestation.
Due to the increased risk of neonatal complications, 
especially if caesarean section must be performed due to 
inefficient induction, labor must not be induced in pregnan-
cies with suspected LGA fetuses before 39 weeks.
Induction of labor in pregnancies with suspected LGA 
fetuses decreases the need for caesarean section and dif-
ficult operative delivery [24]. However, the exact size of the 
fetus must be estimated for the procedure to be efficient 
and burdened with the least risk of complications. If the 
ultrasound estimated fetal weight is above 4.500 g, labor 
induction should not be performed due to a high risk of 
shoulder dystocia [25].
Recommendations
1. Labor induction in pregnancies with sus-
pected LGA fetuses can be considered after 
39 weeks, as it may reduce the risk of shoul-
der dystocia and caesarean section, but a rel-
atively high risk of error in the ultrasound 
estimation of the fetal weight must be taken 
into account.
2. Labor induction at the estimated fetal weight 
> 4.500 g is not recommended due to a high 
risk of shoulder dystocia.
Suspected intrauterine growth restriction (IUGR)
IUGR generally refers to an estimated fetal weight of less 
than the 10th percentile for the gestational age. It should 
be noted that this group of fetuses includes both healthy, 
227
Board of Experts, Polish Gynecological Society recommendations for labor induction
www. journals.viamedica.pl/ginekologia_polska
to a risk of complications associated with late 
pre-term delivery. 
3. Labor induction in women with suspected 
IUGR is recommended after 37 weeks due to 
an increased risk of intrauterine fetal death.
A twin pregnancy
A twin pregnancy is associated with a higher risk of ob-
stetric failures, including intrauterine death of one or both fe-
tuses, compared to a single pregnancy. A cohort analysis in-
dicates that the risk of perinatal mortality increases in a twin 
pregnancy after 37 weeks in the same way as after 41 weeks 
in a single pregnancy [29]. Failures to a large extent are asso- 
ciated with the presence of a single chorion [30]. In mono-
chorionic diamniotic pregnancies, hemodynamic abnor-
malities related to vascular connections in the placenta 
are associated with a significantly higher risk of mortality 
and morbidity of twins compared to dichorionic pregnan-
cies [31]. In monochorionic monoamniotic pregnancies, 
umbilical cord looping and umbilical cord collision may 
lead to intrauterine asphyxia during labor [32]. Therefore, 
a monoamniotic pregnancy is a contraindication to a vagi-
nal delivery.
When choosing the optimum week of delivery, one 
must, however, take account of the risk of neonatal com-
plications. Data from all twin births that took place in the 
United States between 2007 and 2010 suggest that neonatal 
complications occurred less frequently in twins born be-
tween 37 and 38 weeks of gestation than in those born be-
tween 38 and 39 weeks [33]. Similar results were obtained in 
the analysis of more than 760 twin births in Canada [34]. The 
lowest percentage of neonatal complications was noted in 
cases of births between 36 and 37 weeks in monochorionic 
pregnancies and between 37 and 38 weeks in dichorionic 
pregnancies [30]. An Australian study, in which pregnant 
women with uncomplicated twin pregnancies were ran-
domized for elective birth at 37 weeks of gestation or for 
expectant management, showed that a lower percentage 
of complications occurred in cases of early delivery [35].
Twin delivery is one of the biggest challenges of modern 
obstetrics. Retrospective analyses indicate a higher risk of 
complications in vaginal deliveries compared to elective 
caesarean section [36]. This correlation, however, has not 
been confirmed by the recently published results of a large 
randomized trial Twin Birth Study. Currently, an uncompli-
cated diamniotic twin pregnancy with the cephalic presen-
tation of the first twin is not a contraindication to vaginal 
delivery and labor induction [37]. 
Recommendations
1. Labor induction in twin monochorionic  
diamniotic pregnancy, in the absence of con-
constitutionally small newborns whose body weight and 
length are genetically conditioned (small for gestational 
age — SGA) and the fetuses that have failed to achieve 
their growth potential due to pathology and are classi-
fied as having IUGR. In contrast to the IUGR group, there 
is no increased risk of intrauterine death or hemodynamic 
abnormalities in the SGA group of fetuses. About 10% of 
perinatal mortality is due to IUGR. The risk of perinatal death 
in a child with a birth weight of < 10th percentile is twice 
as high as in an infant with a normal birth weight [26, 27]. 
Obstetric management in suspected fetal growth disorders 
involves estimating gestational age based on the crown 
rump length (CRL) measured in the first trimester of preg-
nancy or the transverse cerebellar diameter measured in the 
second trimester (if the CRL is unavailable). Serial ultrasound 
measurements carried out at intervals of two weeks should 
determine the potential growth of the fetus and assess 
the vascular flow. If irregularities are confirmed and IUGR 
is diagnosed, the patient should be directed to a tertiary 
referral center. Depending on the severity of hemodynamic 
changes and the week of gestation, the well-being of the 
fetus should be monitored through Doppler assessment 
of the umbilical artery, the middle cerebral artery, ductus 
venosus and cardiotocography (CTG) for early diagnosis of 
fetal decompensation [27, 28].
Due to the lack of methods of treatment and preven-
tion of IUGR, the labor is the only effective way to affect the 
course of this disease. Labor should be considered if the risk 
of death or harm to the fetus resulting from remaining in 
utero is higher than the risk of complications resulting from 
pre-term birth. The decision on the optimum date of the 
labor should be made by an obstetric and neonatal council 
and discussed with a patient.
According to research results, SGA fetus without con-
comitant pathology should be delivered at term. SGA itself 
is not an indication for induction of labor. In IUGR pregnan-
cies without sights of fetal decompensation, delivery can be 
postponed to 37 weeks [28].
 It should be taken into account that intrauterine growth 
restriction developing after 34 weeks of gestation is not 
always associated with abnormal umbilical blood flow; 
hemodynamic changes may be slightly increased and re-
late mainly to a reduced pulsatility index in the middle 
cerebral artery [26]. 
Recommendations
1. Labor induction in women with IUGR is not 
recommended before 34 weeks of gestation 
due to a high risk of complications associated 
with pre-term delivery. 
2. Labor induction in women with IUGR is not 
recommended between 34 and 36 weeks due 
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traindications to vaginal delivery, should be 
considered between 36 and 37 weeks of ges-
tation due to an increased risk of the intrau-
terine death of the fetus/fetuses.
2. Labor induction in twin dichorionic preg-
nancy, in the absence of contraindications 
to vaginal delivery, should be considered 
between 37 and 38 weeks of gestation due 
to an increased risk of the intrauterine death 
of the fetus/fetuses.
3. Labor induction in twin monoamniotic preg-
nancy is contraindicated.
A pregnancy complicated by hypertension
Hypertension occurs in some 10% of pregnancies and 
is associated with an increased risk of both maternal and 
fetal complications. Pre-eclampsia and hemorrhage into 
the central nervous system are complications associated 
with the highest mortality rate. Hypertension often leads 
to iatrogenic pre-term delivery, intrauterine growth retarda-
tion and caesarean section. Studies indicate that in the ab-
sence of additional complications, delivery between 38 and 
39 weeks of gestation compensates for the risk of maternal 
and neonatal complications [38, 39]. Early delivery should be 
considered in cases of ineffective antihypertensive therapy 
or intrauterine growth retardation.
Recommendations
1. Labor induction in pregnant women with 
uncomplicated hypertension should be con-
sidered after 38 weeks of gestation due to 
an increased risk of maternal complications.
2. Delivery should be considered in women with 
hypertension and additional complications, 
regardless gestational age. Labor approach 
need to be adequate to clinical conditions. 
A pregnancy complicated by diabetes mellitus
Type 1 and type 2 pregestational diabetes occurs in 
about 1% of pregnant women. In recent years, there has 
been an increase in the incidence of type 2 diabetes in 
women of childbearing age due to the obesity epidemic. 
Hyperglycemia and obesity are risk factors for fetal ab-
normalities, excessive growth of the fetus, hypertension 
and pre-eclampsia. The severity of diabetic nephropathy 
and retinopathy may also increase in pregnancy. Hyper-
glycemia and the resulting fetal hyperinsulinemia affect 
the severity of metabolic processes and intrauterine fe-
tal growth. The resulting increased demand for oxygen 
can lead to chronic hypoxia and even death of the fetus 
in particular at the end of the third trimester of pregnan-
cy. Excessive fetal growth is a risk factor for feto-pelvic 
disproportion and shoulder dystocia. The estimated fe-
tal weight above 4000 g and/or the difference between 
abdominal diameter (AD) and biparietal diameter (BPD) 
above 2.6 cm have predictive values for shoulder dystocia 
in diabetic pregnancy [40]. Earlier induction of labor may 
reduce the risk of complications associated with fetal mac-
rosomia. Unfortunately, fetal hyperinsulinemia inhibits type 
II pneumocyte maturation and surfactant production. In-
fants born to mothers with pregestational diabetes are more 
likely to have respiratory distress syndrome before 39 weeks 
of gestation, compared to children of mothers without dia-
betes. There are no studies evaluating the optimum week 
of delivery and induction of labor in pregnant women with 
pregestational diabetes. A randomized trial was conducted 
over 20 years ago in pregnant women with diabetes treated 
with insulin, of which only 6% had pregestational diabetes 
[41]. Induction of labor at 38 weeks was compared with 
expectant management and a lower percentage of fetal 
macrosomia in active management was found.
In the majority of cases, gestational diabetes is diag-
nosed in the second half of pregnancy in approximately 
3.5–5% of Caucasian women. Growing overweight and 
obesity among women of childbearing age and changes 
in the criteria for diagnosing gestational diabetes increase 
the incidence of gestational diabetes. Just as in pregesta-
tional diabetes, the main complications are excessive fetal 
growth, gestational hypertension, shoulder dystocia and 
caesarean section. Recent observational and randomized 
studies have shown that induction of labor in pregnan-
cy complicated by gestational diabetes between 38 and 
40 weeks reduces the risk of stillbirth and caesarean section 
compared to expectant management [42, 43]. No increased 
risk of neonatal complications has been found in cases of 
induction at 39 weeks of gestation.
Recommendations
1. Labor induction in women with pregestatio- 
nal diabetes mellitus should be considered 
after 38 weeks due to an increased risk of 
fetal complications.
2. Labor induction in pregnancy complicated 
gestational diabetes should be considered 
after 39 weeks due to an increased risk of 
fetal complications.
3. In case of suspected excessive fetal growth 
in diabetic pregnancy when the estimated 
fetal weight exceeds above 4000 g and/or 
the difference between AD and BPD above 
2.6 cm, the induction of labor is contradicted 
due to an increased risk of shoulder dystocia. 
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A pregnancy complicated by intrahepatic 
cholestasis
Intrahepatic cholestasis of pregnancy (ICP) occurs in 
approximately 2% of pregnant women. It usually manifests 
itself in the third trimester of pregnancy and is associated 
with severe itching of the skin. The basic criterion for diag-
nosing ICP is an increased concentration of bile acids. While 
ICP has a slight impact on the maternal health, it is a sig-
nificant risk factor for fetal complications including still-
birth. The incidence of intrauterine fetal death increases 
with the duration of pregnancy and the concentration of 
bile acids. Observational studies indicate an increased risk 
after 37 weeks of gestation in cases of severe cholestasis 
with bile acid concentration greater than 100 mmol/L [44]. 
Meconium-stained amniotic fluid also often occurs in preg-
nancies complicated by cholestasis and bile acid concentra-
tion greater than 40 mmol/L, which is often attributed to 
fetal hypoxia. Unfortunately, there are currently no studies 
that would make it possible to identify fetuses at risk of 
intrauterine hypoxia and stillbirth. Therefore, one of the 
recommended procedures is earlier induction of labor. There 
are unfortunately no randomized trials allowing for deter-
mining the optimum date of delivery. Retrospective studies 
suggest that induction of labor in pregnant women with 
cholestasis gives similar obstetric results to conservative 
treatment in a population of healthy pregnant women. 
A lower number of stillbirths have also been found in cases 
of induction at 37 weeks compared to historical controls [45]. 
A retrospective analysis of a cohort of pregnant women with 
and without cholestasis indicates that delivery at 36 weeks 
reduces the risk of intrauterine fetal demise and compen-
sates for the risk of neonatal complications [46]. Given the 
lack of randomized trial-based recommendations for op-
timal management of ICP, most experts suggest inducing 
labor between 36 and 37 weeks of pregnancy, especially 
if the concentration of bile acids exceeds 40 mmol/L [47].
Recommendation
Labor induction in pregnancies complicated by ICP 
is recommended due to a risk of fetal complications 
if the concentrations of bile acids are:
 Ū ≥ 100 mmol/L after 34 weeks of gestation;
 Ū 40–99 mmol/L after 36 weeks of gestation;
 Ū 10–39 mmol/L after 38 weeks of gestation.
Labor induction in pregnant women of advanced 
reproductive age
The risk of pregnancy complications, including un-
explained stillbirth and maternal mortality, increases in 
women of advanced reproductive age [48]. The mechanism 
responsible for the increased risk of intrauterine fetal death 
without structural defects in older women has not been 
explained so far. A meta-analysis of randomized trials has 
shown that induction of labor in women over 35 years of age 
is not associated with an increased risk of maternal or fetal 
complications and caesarean section [49, 50]. Due to the 
risk of stillbirth in pregnant women of advanced reproduc-
tive age, it is recommended to treat pregnancies of women 
aged 40 and more as biologically mature at 39 weeks and 
consider the possibility of labor induction.
Recommendation
Labor induction in pregnant women over the age 
of 40 is recommended after 39 weeks of gestation 
due to an increased risk of intrauterine fetal death.
INDUCTION OF LABOR  
— CONDITIONS AND METHODS
The maturity of the cervix
The morphological and functional maturity of the cer-
vix determines successful labor induction. The first scoring 
system allowing for the assessment of cervical maturity was 
the Bishop score described in 1964 [51]. It is assumed that 
the cervix is prepared for the induction of labor at a score 
of at least 6 (Tab. 4).
A meta-analysis of studies comparing the Bishop score 
and transvaginal sonography in the evaluation of the maturity 
of the cervix before labor induction has shown that neither 
of these methods is more effective in determining clinically 
relevant endpoints including the date of labor induction [52]. 
Therefore, the Bishop score remains the most commonly re- 
commended method for assessing the maturity of the cervix.
Pre-induction of labor in unripe cervix
The current methods of labor pre-induction include 
pharmacological (prostaglandin E2 — dinoprostone and 
prostaglandin E1 — misoprostol) and mechanical methods 
(membrane stripping, artificial rupture of membranes, 
a Foley catheter and a double-balloon catheter).
The use of mechanical methods  
for labor pre-induction
The mechanical methods involve direct dilation of the 
cervix and the lower uterine segment (Tab. 5). 
The use of a Foley catheter for labor pre-induction
A urinary Foley catheter is among the most common 
non-pharmacological methods used for labor pre-induction. 
Its application was first described in 1863. Cervical ripen-
ing with a Foley catheter involves direct dilation of the 
cervix and the lower uterine segment using a saline-filled 
balloon, as well as membrane stripping to increase local 
prostaglandin release.
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Table 3. Strength of recommendations
Strength of recommendations
Level A — recommendations are based on evidence obtained from randomized, controlled trials
Level B — recommendations are based on evidence obtained from controlled trials without randomization
Level C— recommendations are based on evidence obtained from cohort or case–control analytic studies and from multiple time series with or 
without the intervention
Level D — recommendations are based on expert committee reports or opinions or clinical experience of respected authorities
Table 2. Summary of recommendations
Summary of recommendations
1. The decision to induce labor should always be justified on medical grounds and preceded by obtaining a written informed consent from the 
pregnant woman. (Level D)
2. Labor induction is recommended in well-dated pregnancies (taking account of fetal biometry between 8 and 14 weeks of gestation) at 
41 weeks to 41 weeks + 6 days, regardless of the state of the cervix, taking account of the fact that interventions at this time reduce perinatal 
mortality without increasing perinatal morbidity or the percentage of caesarean sections. (Level A)
3. Labor induction is not recommended in pregnant women with PPROM before 34 weeks of gestation in the absence of symptoms of 
intrauterine infection due to a high risk of complications associated with pre-term birth. Expectant management using a steroid therapy and 
antibiotic prophylaxis is recommended. (Level A)
4. Labor induction is not recommended in pregnant women with PPROM between 34 and 37 weeks of gestation in the absence of symptoms 
of intrauterine infection because it does not reduce the risk of complications of neonatal sepsis and may be associated with a higher risk of 
respiratory complications in newborns. Expectant management with prophylactic antibiotics is recommended. (Level A)
5. Delivery in women with PPROM is recommended in cases of intrauterine infection, regardless the gestational age. Labor approach need to be 
adequate to clinical conditions. (Level D)
6. Labor induction is recommended in pregnant women with PPROM after 37 weeks of gestation due to a reduced risk of maternal and neonatal 
complications. (Level A)
7. Labor induction in pregnancies with suspected LGA fetuses can be considered after 39 weeks, as it may reduce the risk of shoulder dystocia 
and caesarean section, but a relatively high risk of error in the ultrasound estimation of the fetal weight must be taken into account. (Level A)
8. Labor induction at the estimated fetal weight exceeded 4.500 g is not recommended due to a high risk of shoulder dystocia. (Level C)
9. Labor induction in women with IUGR is not recommended before 34 weeks of gestation due to a high risk of complications associated with 
pre-term delivery. (Level A)
10. Labor induction in women with IUGR is not recommended between 34 and 36 weeks due to a risk of complications associated with late pre-
term delivery. (Level A)
11. Labor induction in women with suspected IUGR is recommended after 37 weeks due to an increased risk of intrauterine fetal death. (Level C)
12. Labor induction in twin monochorionic diamniotic pregnancy, in the absence of contraindications to vaginal delivery, should be considered 
between 36 and 37 weeks of gestation due to an increased risk of the intrauterine death of the fetus/fetuses. (Level B)
13. Labor induction in twin dichorionic pregnancy, in the absence of contraindications to vaginal delivery, should be considered between 37 and 
38 weeks of gestation due to an increased risk of the intrauterine death of the fetus/fetuses. (Level A)
14. Labor induction in twin monoamniotic pregnancy is contraindicated. (Level D)
15. Labor induction in pregnant women with uncomplicated hypertension should be considered after 38 weeks of gestation due to an increased 
risk of maternal complications. (Level A)
16. Delivery should be considered in women with hypertension and additional complications, regardless gestational age. Labor approach need to 
be adequate to clinical conditions. (Level D)
17. Labor induction in women with pregestational diabetes mellitus should be considered after 38 weeks due to an increased risk of fetal 
complications. (Level C)
18. Labor induction in pregnancy complicated gestational diabetes should be considered after 39 weeks due to an increased risk of fetal 
complications. (Level C)
19. In case of suspected excessive fetal growth in diabetic pregnancy when the estimated fetal weight exceeds above 4000 g and/or the difference 
between AD and BPD above 2.6 cm, the induction of labor is contradicted due to an increased risk of shoulder dystocia. (Level C)
20. Labor induction in pregnancies complicated by ICP is recommended due to a risk of fetal complications if the concentrations of bile acids are 
(Level C):
 — > 100 mmol/L after 34 weeks of gestation;
 — 40–100 mmol/L after 36 weeks of gestation;
 — 10–39 mmol/L after 38 weeks of gestation.
21. Labor induction in pregnant women over the age of 40 is recommended after 39 weeks of gestation due to an increased risk of intrauterine 
fetal death. (Level B)
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Table 4. The assessment of cervical maturity — Bishop score
Factor
Score
0 1 2
Dilation (cm) 0 1–2 3–4
Effacement (%) 0–30 40–50 60–70
Consistency Firm Medium Soft
Position Posterior Midposition Anterior
Station –3 –2 –1 
The use of a Foley catheter for labor pre-induction is 
a simple and cheap method and it has few side effects 
compared to pharmacological agents used for cervical 
ripening [53]. In 2012, the Cochrane Database published 
a meta-analysis of the effectiveness of mechanical methods 
in pre-induction of labor. The authors have concluded that 
the effectiveness of mechanical methods is comparable to 
that of prostaglandins in inducing labor within 24 hours at 
a comparable risk of caesarean section and a lower risk of 
hyperstimulation of the uterus [54].
A double-balloon catheter  
— Cook cervical ripening balloon
In 1991, Dr Atad from Israel published the first report 
on a double-balloon catheter (DBC) designed specifically 
for labor pre-induction. The current model of this catheter 
consists of a rigid stylet and two balloons: a uterine bal-
loon which is positioned in the cervical internal os and 
a cervical-vaginal balloon for positioning at the cervical 
external os. The mechanism of action is similar to that of 
a Foley catheter. Studies on the efficiency of DBC have de- 
monstrated that its efficacy for cervical ripening is  higher 
than or comparable with pharmacological methods [55].
The use of prostaglandins for labor pre-induction
Any obstetric situations requiring vaginal termination of 
pregnancy in patients with concomitant unripe cervix are 
indications for the application of prostaglandins [56] (Tab. 6).
Nowadays two prostaglandins are accepted for use 
in pre-induction of labor with a live fetus, as well as in 
abortion/delivery of a stillbirth fetus and non-viable fetus 
in Poland. These are PGE2 (dinoprostone — vaginal gel 
[0.5 mg/3 g] and a vaginal delivery system [0.005 g/12 h]) 
and PGE1 (misoprostol — a vaginal delivery system com-
prising 200 µg of misoprostol with a release rate of 7 µg/h).
A meta-analysis has shown that the vaginal delivery 
of prostaglandins is the most effective method in labor 
pre-induction compared to other routes of administration 
[57]. When choosing prostaglandin for labor pre-induction, 
one should remember that these two molecules differ sig-
nificantly in terms of pharmacokinetics: misoprostol has 
a much stronger uterotonic effect than dinoprostone and 
is therefore more effective in less mature cervix, e.g. in pri-
miparous women. 
Induction of labor in mature cervix 
The use of oxytocin for labor induction
The indication for oxytocin use is the need for labor in-
duction in mature cervix. Studies have shown that the high-
est doses of oxytocin are needed in primiparous women, 
before the 36th week of pregnancy, at the cervical dilation 
of less than 2 cm [58]. The Cochrane Database contains 
a recently published meta-analysis comparing the efficacy 
of different doses of oxytocin in labor induction [59]. This 
comparison has shown no clinically relevant differences with 
the exception of an increased risk of uterine hyperstimula-
tion associated with higher doses of oxytocin.
Data published in 2004 show that prolonged infusion 
of oxytocin after reaching an effective uterine contractions 
Table 5. Contraindications to mechanical dilation of the cervix
Contraindications to mechanical dilation of the cervix
Vaginal bleeding
Placenta previa
Premature rupture of membranes — relative contraindication
Table 6. Contraindications to the use of prostaglandins
Contraindications to the use of prostaglandins
Uterine scarring after previous cesarean sections or other operations
Feto-pelvic disproportion
Previous operative deliveries (with forceps or ventouse)
Six or more deliveries in the past
Presentation other than the longitudinal cephalic presentation
Symptoms of acute health risks to the fetus
Rupture of membranes — relative contraindication
Allergy to prostaglandins or carrier components
Bronchial asthma, glaucoma or elevated intraocular pressure
Placenta previa, unexplained vaginal bleeding
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and the start of the active phase of labor does not bring any 
clear benefits (cervical dilation > 5 cm) [60].
The most serious complication of labor induction with 
oxytocin is uterine hyperstimulation, which is associated 
with a risk of prolonged tonic contractions and fetal hypoxia. 
The greatest risk of uterine rupture occurs in women who 
had a surgery on the uterus in the past and in multiparous 
women. 
Membrane stripping 
Membrane stripping or membrane sweeping is me-
chanical separation of membranes from the lower uterine 
segment to initiate local prostaglandin release and hasten 
labor. The simultaneous insertion of one or two fingers 
through the cervical os initiates endogenous oxytocin re-
lease and the Ferguson reflex.
This intervention is highly efficient and helps avoid labor 
induction using conventional pharmacological methods 
and amniotomy. When used as an adjunct to other labor 
induction techniques, this method allows for decreasing 
doses of oxytocin and increasing the percentage of vaginal 
deliveries [61]. Routine use of this treatment from 38 weeks 
of pregnancy does not bring any clinically significant be- 
nefits. Complications associated with membrane stripping 
include infection, bleeding and accidental rupture of mem-
branes and are relatively rare.
The use of amniotomy for induction of labor
Amniotomy is artificial rupture of membranes, which 
leads to the stimulation of uterine contractility through 
the release of prostaglandins and oxytocin to accelerate or 
shorten labor. This procedure was first described in 1756. 
It is currently one of the most commonly performed pro-
cedures in obstetrics [62]. Performing amniotomy at cervi-
cal dilation of less than 2 cm and immature cervix (hard, 
pointing toward the sacrum) is associated with an increased 
incidence of labor dystocia, ascending infection and cae-
sarean sections [62]. If the cervix is dilated to 3–4 cm after 
the spontaneous start of labor, amniotomy can shorten 
the active phase of dilation by more than a third (Tab. 7, 8).
When making a decision to perform amniotomy, one 
should consider the risks associated with the procedure, 
such as umbilical cord prolapse, acute fetal hypoxia, fetal 
damage, abnormal engagement of the head, as well as the 
risk of intrauterine infection in the case of prolonged rupture 
of membranes. Intrauterine infection (if delivery takes longer 
than 12 hours) can be prevented by antibiotic therapy and 
less frequent vaginal examinations.
The largest study published to date of the efficacy of 
amniotomy is labor induction in mature cervix involved 
more than 3.500 patients. The study has shown that this 
method is useful as a sole method of labor induction [62].
The clinical utility of early amniotomy after the removal 
of a Foley catheter has also been analyzed. It has been found 
that the rapture of membranes not later than one hour after 
removal of the catheter significantly reduces the duration 
of induction in nulliparous women [63].
Furthermore, the cost-effectiveness of early amniotomy 
has been compared after the application of vaginal gel 
containing PGE2 in patients with Bishop score < 7. It has 
been found that amniotomy is more cost-effective than a re-
peated vaginal administration of prostaglandin [64].
Induction of labor in intrauterine fetal death
Administering misorpostol is the most effective method 
of inducing labor in intrauterine fetal death at < 28 weeks 
of pregnancy, regardless of the outcome of a clinical as-
sessment of cervical maturity  [65]. Misoprostol must not 
be used in third-trimester intrauterine fetal death after cae-
sarean section due to a risk of uterine rupture (1.2–10%). 
Using a Foley catheter is a useful method of inducing labor 
in intrauterine fetal death at > 28 weeks of pregnancy. If 
administration of oxytocin is necessary, it can be infused 
intravenously 4 hours after the last dose of misoprostol. 
Table 7. Preconditions for amniotomy
Preconditions for amniotomy
Careful obstetric interview and evaluation of test results
Engagement of the presenting part of the fetus in the pelvic inlet
Favorable Bishop score assessment of the cervix
Aseptic and antiseptic conditions
Table 8. Contraindications to amniotomy
Absolute contraindications
Abnormal fetal presentation: small parts first (including the 
umbilical cord)
Vasa previa
Vaginosis
Breech presentation
Absolute indications for cesarean section
Relative contraindications
Polyhydramnios
No engagement of the head in the pelvis
Pre-term delivery
Unripe cervix
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